Developmental dysplasia of the hip: universal or selective ultrasound screening?

Jiun Lee1

  • 1Department of Neonatology, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074. Lee_Jiun@nuhs.edu.sg

Insights

Developmental dysplasia of the hip (DDH) screening requires careful consideration. Selective ultrasound screening for infants with risk factors is more effective and cost-efficient than universal screening.

Area of Science:

  • Pediatrics
  • Orthopedics
  • Medical Imaging

Background:

  • Developmental dysplasia of the hip (DDH) evolves during infancy, making early, perfectly accurate screening challenging.
  • Current clinical screening methods for DDH may miss a significant number of cases requiring surgery.
  • There is ongoing debate regarding the optimal screening strategy for DDH due to limited epidemiological data.

Purpose of the Study:

  • To review and compare different screening strategies for developmental dysplasia of the hip.
  • To evaluate the effectiveness and cost-efficiency of universal versus selective ultrasound screening for DDH.
  • To provide guidance for healthcare systems considering DDH screening protocols.

Main Methods:

  • Literature review on developmental dysplasia of the hip screening methods.
  • Analysis of universal versus selective ultrasound screening approaches.
  • Evaluation of reported outcomes, including detection rates and surgical reductions.

Main Results:

  • Universal ultrasound screening for DDH can lead to significant reductions in late surgical interventions but is associated with high false positive rates and costs.
  • Selective ultrasound screening, targeting high-risk infants, has shown similar reductions in surgery for late DDH.
  • The effectiveness and cost-benefit analysis suggest universal screening is not generally cost-effective.

Conclusions:

  • Neither universal nor selective screening at birth guarantees high sensitivity and specificity for DDH.
  • Selective ultrasound screening for infants with identified risk factors appears to be a more pragmatic approach.
  • Healthcare systems should carefully weigh the pros and cons, favoring cost-effective strategies like selective screening over universal screening for DDH.